Ulf Andreasson

Overview

Best Publications

• CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

  Bob Olsson;Ronald Lautner;Ulf Andreasson;Annika Öhrfelt

  2170
  Citations

• Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

  Jens Kuhle;Christian Barro;Ulf Andreasson;Tobias Derfuss

  758
  Citations

• Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

  Bridel C;van Wieringen Wn;Zetterberg H;Tijms Bm

  706
  Citations

• Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.

  Niklas Mattsson;Nicholas C. Cullen;Nicholas C. Cullen;Ulf Andreasson;Ulf Andreasson;Henrik Zetterberg

  700
  Citations

• A Practical Guide to Immunoassay Method Validation

  Ulf Andreasson;Armand Perret-Liaudet;Linda J C van Waalwijk van Doorn;Kaj Blennow

  549
  Citations

• Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

  Jacob W. Vogel;Yasser Iturria-Medina;Olof T. Strandberg;Ruben Smith

  522
  Citations

• Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

  Sara Hall;Annika Öhrfelt;Radu Constantinescu;Ulf Andreasson

  510
  Citations

• Plasma tau in Alzheimer disease

  Niklas Mattsson;Henrik Zetterberg;Henrik Zetterberg;Henrik Zetterberg;Shorena Janelidze;Philip S. Insel

  505
  Citations

• Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

  Vladimir Coric;Christopher H. van Dyck;Stephen Salloway;Niels Andreasen

  493
  Citations

• Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

  Magnus Gisslén;Richard W. Price;Ulf Andreasson;Niklas Norgren

  488
  Citations

• Blood-based NfL : A biomarker for differential diagnosis of parkinsonian disorder

  Oskar Hansson;Shorena Janelidze;Sara Hall;Nadia Magdalinou

  480
  Citations

• Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

  Jonathan D. Rohrer;Ione O.C. Woollacott;Katrina M. Dick;Emilie Brotherhood

  457
  Citations

• The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

  Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai

  452
  Citations

• Plasma tau levels in Alzheimer's disease

  Henrik Zetterberg;Henrik Zetterberg;David Wilson;Ulf Andreasson;Lennart Minthon

  415
  Citations

• Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.

  Sebastian Palmqvist;Henrik Zetterberg;Kaj Blennow;Susanna Vestberg

  403
  Citations

• CSF biomarker variability in the Alzheimer's Association quality control program

  Niklas Mattsson;Niklas Mattsson;Ulf Andreasson;Staffan Persson;Maria C. Carrillo

  393
  Citations

• Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid

  Tobias Bittner;Henrik Zetterberg;Henrik Zetterberg;Charlotte E. Teunissen;Richard E. Ostlund

  380
  Citations

• Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

  Hlin Kvartsberg;Flora H. Duits;Martin Ingelsson;Niels Andreasen

  371
  Citations

• Prediction of Alzheimer's Disease Using the CSF Abeta42/Abeta40 Ratio in Patients with Mild Cognitive Impairment.

  Oskar Hansson;Henrik Zetterberg;Peder Buchhave;Ulf Andreasson

  366
  Citations

• Evaluation of plasma A beta(40) and A beta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

  Oskar Hansson;Oskar Hansson;Henrik Zetterberg;Eugeen Vanmechelen;Hugo Vanderstichele

  362
  Citations

• Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.

  Thomas K Karikari;Andréa L Benedet;Nicholas J Ashton;Juan Lantero Rodriguez

  338
  Citations

• Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

  Pashtun Shahim;Magnus Gren;Victor Liman;Ulf Andreasson

  331
  Citations